Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct;61(10):1231-1240.
doi: 10.1007/s00592-024-02275-4. Epub 2024 May 14.

Sex-driven factors associated with anxiety and depression in autoimmune diabetes

Affiliations

Sex-driven factors associated with anxiety and depression in autoimmune diabetes

Enrico Saudelli et al. Acta Diabetol. 2024 Oct.

Abstract

Aim: To analyze the prevalence of anxiety and depression in a large cohort of adults with autoimmune diabetes, identifying sex-driven associated factors.

Materials and methods: In this cross-sectional study, we enrolled 553 consecutive adults with Type 1 diabetes mellitus or latent autoimmune diabetes in adults who came to the Division of Endocrinology of the S.Orsola-Malpighi Polyclinic, Bologna (Italy), to receive their second dose of SARS-CoV-2 vaccine. We administered the questionnaires: Hospital Anxiety and Depression Scale, Diabetes Distress Scale, Diabetes-related Quality of Life, Diabetes Treatment Satisfaction Questionnaire. We collected clinical and biochemical data and 14 days glucose metrics in patients with sensor use > 70% in a time span of ± 4 months from the questionnaires' administration. We excluded 119 patients from our analyses with missing data (final cohort n = 434: 79% of those enrolled).

Results: Anxiety and depression prevalence was respectively 30.4% and 10.8%. According to the multivariate analysis, higher diabete-related emotional burden, lower treatment satisfaction, but not physician-related distress, were risk factors for anxiety and depression; female sex was associated with anxiety (OR 0.51, 95% 0.31-0.81; p = 0.005); in women, depression was associated with increasing age (males vs. females OR 0.96 per 1 year increase, 95% CI 0.92-1.00; p = 0.036), whilst in men with HbA1c (OR 1.08 per 1 mmol/mol increase, 95% CI 1.03-1.13; p = 0.002).

Conclusion: Nearly 1/3 of patients with autoimmune diabetes suffers from anxiety and 1/10 from depression. These conditions are associated with independent modifiable and non-modifiable characteristics. For depression, these characteristics differ between males and females.

Keywords: Autoimmune diabetes; Continuous glucose monitoring; HADS; Hospital Anxiety and Depression Scale; Type 1 diabetes mellitus.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Summary of the main results on the prevalence of anxiety and depression and their independent risk factors. OR, odds ratio; DTSQ: Diabetes Treatment Satisfaction Questionnaire; DDS: Diabetes Distress Scale; EB: Emotional Burden; RD: Regimen Distress; HbA1c, glycated hemoglobin; M = males

Similar articles

References

    1. Giwa AM, Ahmed R, Omidian Z et al (2020) Current understandings of the pathogenesis of type 1 diabetes: genetics to environment. World J Diabetes 11(1):13–25. 10.4239/wjd.v11.i1.13 - PMC - PubMed
    1. Forlani G, Nuccitelli C, Caselli C et al (2013) A psychological support program for individuals with Type 1 diabetes. Acta Diabetol 50(2):209–216. 10.1007/s00592-011-0269-x - PubMed
    1. Patel V, Saxena S, Lund C et al (2018) The Lancet Commission on global mental health and sustainable development. Lancet 392(10157):1553–1598. 10.1016/S0140-6736(18)31612-X - PubMed
    1. Ahola AJ, Thorn LM, Saraheimo M et al (2010) Depression is associated with the metabolic syndrome among patients with type 1 diabetes. Ann Med 42(7):495–501. 10.3109/07853890.2010.503660 - PubMed
    1. Ahola AJ, Harjutsalo V, Forsblom C, Pouwer F, Groop PH, FinnDiane Study Group (2021) Depression is associated with progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 44(1):174–180. 10.2337/dc20-0493 - PubMed

MeSH terms